NCT00915213

Brief Summary

The purpose of this study is to discover how often certain bacteria are found in the rectum at the time of a prostate needle biopsy to diagnose prostate cancer. Certain bacteria are of importance because they can cause serious infection. Antibiotics that urologists commonly use to prevent these bacteria from causing infection are no longer effective. Many physicians around the world are noting increased infections with antibiotic resistant bacteria. Therefore; despite treating patients who are to undergo prostate biopsy with antibiotics, certain patients are being readmitted to the hospital with a serious infection. In order to study the incidence of these particular bacteria, the best method is to culture the bacteria at the time of the biopsy. This involves one rectal culture swab just prior to needle biopsy of the prostate. Once the incidence of these bacteria is known we may take steps to prevent the serious infections that occur as a result of prostate biopsy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
136

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2008

Longer than P75 for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2008

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

June 3, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 5, 2009

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

December 19, 2016

Status Verified

December 1, 2016

Enrollment Period

5.7 years

First QC Date

June 3, 2009

Last Update Submit

December 16, 2016

Conditions

Keywords

E. ColiProstate Biopsy

Study Arms (1)

Repeat Prostate Biopsy

Men who undergo repeat prostate biopsy

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Men undergoing repeat prostate biopsy

You may qualify if:

  • adult males
  • repeat prostate biopsy

You may not qualify if:

  • first time prostate biopsy
  • minors

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Kaiser Permanente

Irvine, California, 92618, United States

Location

Long Beach Veteran Affairs

Long Beach, California, 90822, United States

Location

University of California, Irvine Medical Center

Orange, California, 92868, United States

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Rectal Swab

MeSH Terms

Conditions

Bacterial InfectionsEscherichia coli Infections

Condition Hierarchy (Ancestors)

Bacterial Infections and MycosesInfectionsEnterobacteriaceae InfectionsGram-Negative Bacterial Infections

Study Officials

  • Atreya Dash, MD

    University of California, Irvine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

June 3, 2009

First Posted

June 5, 2009

Study Start

October 1, 2008

Primary Completion

June 1, 2014

Study Completion

December 1, 2014

Last Updated

December 19, 2016

Record last verified: 2016-12

Locations